Sodium cation

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Sodium cation
Accession Number
DB14516
Description
Not Available
Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 22.9898
Monoisotopic: 22.989769675
Chemical Formula
Na
Synonyms
  • Sodium (ion)
  • Sodium ion
  • sodium(1+)

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Sodium cation.
AclidiniumThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Aclidinium.
AlfentanilThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Alfentanil.
AlloinThe risk or severity of adverse effects can be increased when Sodium cation is combined with Alloin.
AlmasilateThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Almasilate.
Aluminium phosphateThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Aluminium phosphate.
Aluminum hydroxideThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Aluminum hydroxide.
AmantadineThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Amantadine.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Sodium cation.
AmiodaroneThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Amiodarone.
Additional Data Available
  • Extended Description
    Extended Description
    Available for Purchase

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity
    Available for Purchase

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level
    Available for Purchase

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action
    Available for Purchase

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
NinePercentSodium cation (90 g/1000g)Injection, solutionIntravenousUS Specialty Formulations LLC2014-12-01Not applicableUS flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
LYR4M0NH37
CAS number
17341-25-2
InChI Key
FKNQFGJONOIPTF-UHFFFAOYSA-N
InChI
InChI=1S/Na/q+1
IUPAC Name
sodium(1+) ion
SMILES
[Na+]

References

General References
Not Available
Human Metabolome Database
HMDB0000588
KEGG Compound
C01330
ChemSpider
899
RxNav
1364429
ChEBI
29101
PDBe Ligand
NA
PDB Entries
131d / 191d / 192d / 193l / 194l / 1a2c / 1a3d / 1a46 / 1a4w / 1a50
show 9377 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4RecruitingPreventionCardiac Surgical Procedures1
4RecruitingTreatmentHeart; Surgery, Heart, Functional Disturbance as Result1
Not AvailableCompletedTreatmentAortic Valve Disorder / Ischemia-Reperfusion Injury1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Granule, for solutionOral7.5 mmol
Injection, solutionIntravenous2.5 g/1000ml
SuspensionOral540 mg/5ml
Tablet, chewableOral480 mg
Injection, powder, for solutionIntravenous2 g/vial
Injection, solutionIntracardiac5.1 mg/100mL
Tablet, extended releaseOral500 MG
Tablet, delayed releaseOral1000 mg
SolutionOral1.45 mmol/15mL
Injection, solutionIntravenous90 g/1000g
Injection, emulsionIntravenous120 g
Injection, emulsionIntravenous160 g
Injection, emulsionIntravenous150 g
Injection, emulsionIntravenous225 g
Injection, emulsionIntravenous300 g
EmulsionIntravenous150 g
EmulsionIntravenous225 g
SolutionIntraperitoneal510 mg/l
Injection, emulsionIntravenous3.66 g
Injection, emulsionIntravenous5.5 g
Injection, emulsionIntravenous7.33 g
Injection, emulsionIntravenous9.16 g
SolutionIntravenous129.3 mEq/L
Powder, for solutionOral3.1 meq/100mL
SolutionIntravenous12 g/L
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-0.77ChemAxon
pKa (Strongest Acidic)3.09ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m3·mol-1ChemAxon
Polarizability1.78 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-25bf08b0ab99f8116a31
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-25bf08b0ab99f8116a31
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-25bf08b0ab99f8116a31
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-fba837e9c7559de06780
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-fba837e9c7559de06780
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9000000000-fba837e9c7559de06780

Drug created on July 12, 2018 10:35 / Updated on June 12, 2020 10:53